Literature DB >> 19215578

Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles.

T N Q Pham1, S E Mercer, T I Michalak.   

Abstract

Hepatitis C virus (HCV) replicates in immune cells in both chronic hepatitis C (CHC) and occult HCV infection, but the extent of virus replication in this compartment in these opposing infection forms varies greatly. It was unknown whether this could be linked to HCV genotype or to differences in host gene expression shaping the immune response, and whether HCV replication in immune cells is sensitive to endogenous antiviral cytokines. In this study, we uncovered that significantly greater HCV load in peripheral blood mononuclear cells (PBMC), but not in plasma, coincided with HCV genotypes 2 and 3 in CHC, but with genotype 1 in residual occult infection after clinical resolution of hepatitis C. Moreover, PBMC from individuals with occult infection transcribed significantly greater levels of IFN-alpha, IFN-gamma and TNF-alpha, but less interleukin (IL)-10 than those from CHC. In CHC, PBMC with low HCV load expressed significantly more IFN-gamma but less IL-12 than did cells with high virus content. In occult infection, HCV RNA detection in PBMC was associated with much lower IFN-alpha and IL-12 expression. Further, HCV replication in T lymphocytes could be completely eliminated by activation of endogenous IFN-gamma in CHC, but of IFN-alpha in occult infection. In conclusion, CHC and persistent occult HCV infection are characterized by clearly different profiles of antiviral cytokine response in circulating immune cells which are also different from those of healthy individuals. Higher expression of IL-10, combined with lower transcription of IFN-alpha, IFN-gamma and TNF-alpha, is associated with a more robust HCV replication in immune cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215578     DOI: 10.1111/j.1365-2893.2009.01092.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  15 in total

1.  Hepatitis C virus infection of human T lymphocytes is mediated by CD5.

Authors:  Mohammed A Sarhan; Tram N Q Pham; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  New perspectives in occult hepatitis C virus infection.

Authors:  Vicente Carreño; Javier Bartolomé; Inmaculada Castillo; Juan Antonio Quiroga
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

3.  Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

Authors:  Eduardo Vilar Gomez; Yadina Martinez Perez; Hector Vega Sanchez; Gretel Riveron Forment; Enrique Arus Soler; Luis Calzadilla Bertot; Ali Yasells Garcia; Maria del Rosario Abreu Vazquez; Licet Gonzalez Fabian
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

4.  Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.

Authors:  Mohammed A Sarhan; Annie Y Chen; Tomasz I Michalak
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy.

Authors:  Ambreen G Muazzam; Saleem Qureshi; Atika Mansoor; Lubna Ali; Musarrat Iqbal; Saima Siddiqi; Khalid M Khan; Kehkashan Mazhar
Journal:  Genet Vaccines Ther       Date:  2011-09-06

Review 6.  Occult HCV Infection: The Current State of Knowledge.

Authors:  Mohammad Saeid Rezaee-Zavareh; Reza Hadi; Hamidreza Karimi-Sari; Mohammad Hossein Khosravi; Reza Ajudani; Fardin Dolatimehr; Mahdi Ramezani-Binabaj; Seyyed Mohammad Miri; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2015-11-29       Impact factor: 0.611

7.  Occult HCV infection: an unexpected finding in a population unselected for hepatic disease.

Authors:  Laura De Marco; Anna Gillio-Tos; Valentina Fiano; Guglielmo Ronco; Vittorio Krogh; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Franco Merletti; Lorenzo Richiardi; Carlotta Sacerdote
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

8.  Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.

Authors:  Samar Samir Youssef; Aml S Nasr; Taher El Zanaty; Rasha Sayed El Rawi; Mervat M Mattar
Journal:  Hepat Res Treat       Date:  2012-12-12

9.  Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus Treatment.

Authors:  Paul Ravi Waldron; Mark Holodniy
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

Review 10.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.